Search

Your search keyword '"Lee, Mei-Hsuan"' showing total 602 results

Search Constraints

Start Over You searched for: Author "Lee, Mei-Hsuan" Remove constraint Author: "Lee, Mei-Hsuan"
602 results on '"Lee, Mei-Hsuan"'

Search Results

1. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

2. Novel lissencephaly-associated NDEL1 variant reveals distinct roles of NDE1 and NDEL1 in nucleokinesis and human cortical malformations

4. Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry

5. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

7. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

8. THU-365 Real-world effectiveness and safety of 8-week glecaprevir/ pibrentasvir for treatment-naïve patients from Taiwan nationwide HCV registry

9. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

10. Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project

14. Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease

15. The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients

16. Long-term Risks for Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes

18. Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan

19. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

20. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)

21. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

22. Epidemiology of Virus Infection and Human Cancer

23. Lissencephaly-associated BAIAP2 variant causes defects in neuronal migration during brain development

25. Clinical outcome of bevacizumab or ramucirumab combined with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors as the first line therapy in susceptible EGFR‐mutated advanced non‐small‐cell lung.

26. Persistently high HBsAg levels during HBeAg‐seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.

27. Clinical and Genotypic Insights Into Higher Prevalence of Palbociclib Associated Neutropenia in Asian Patients.

31. Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan

33. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

35. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

39. Epidemiology of Virus Infection and Human Cancer

40. Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review

41. The impact of HCV cure on glycemic indices in patients using glecaprevir/pibrentasvir from nationwide Taiwan HCV registry

43. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

46. Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease

49. Data from Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer

Catalog

Books, media, physical & digital resources